Classification model of amino acid sequences prone to aggregation of therapeutic proteins
- PMID: 27388622
- PMCID: PMC4937009
- DOI: 10.1186/s40203-016-0019-4
Classification model of amino acid sequences prone to aggregation of therapeutic proteins
Abstract
Background: Total body clearance of biological drugs is for the most part dependent on the receptor mechanisms (receptor mediated clearance) and the concentration of antibodies aimed at administered drug - anti-drug-antibodies (ADA). One of the significant factors that induces the increase of ADA level after drug administration could be the aggregates present in the finished product or formed in the organism. Numerous attempts have been made to identify the sequence fragments that could be responsible for forming the aggregates - aggregate prone regions (APR).
Purpose: The aim of this study was to find physiochemical parameters specific to APR that would differentiate APR from other sequences present in therapeutic proteins.
Methods: Two groups of amino acid sequences were used in the study. The first one was represented by the sequences separated from the therapeutic proteins (n = 84) able to form APR. A control set (CS) consisted of peptides that were chosen based on 22 tregitope sequences.
Results: Classification model and four classes (A, B, C, D) of sequences were finally presented. For model validation Cooper statistics was presented.
Conclusions: The study proposes a classification model of APR. This consists in a distinction of APR from sequences that do not form aggregates based on the differences in the value of physicochemical parameters. Significant share of electrostatic parameters in relation to classification model was indicated.
Keywords: ADA; Aggregates; Immunogenicity; In silico; Proteins.
Figures


Similar articles
-
Aggregation prone regions and gatekeeping residues in protein sequences.Curr Top Med Chem. 2012;12(22):2470-8. doi: 10.2174/1568026611212220003. Curr Top Med Chem. 2012. PMID: 23339301 Review.
-
Sequence dependent aggregation of peptides and fibril formation.J Chem Phys. 2017 Sep 14;147(10):105102. doi: 10.1063/1.5001517. J Chem Phys. 2017. PMID: 28915764
-
Relationship between potential aggregation-prone regions and HLA-DR-binding T-cell immune epitopes: implications for rational design of novel and follow-on therapeutic antibodies.J Pharm Sci. 2012 Aug;101(8):2686-701. doi: 10.1002/jps.23169. Epub 2012 May 22. J Pharm Sci. 2012. PMID: 22619033
-
Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.Sci Rep. 2016 Feb 29;6:22258. doi: 10.1038/srep22258. Sci Rep. 2016. PMID: 26924748 Free PMC article.
-
Emerging issues of connexin channels: biophysics fills the gap.Q Rev Biophys. 2001 Aug;34(3):325-472. doi: 10.1017/s0033583501003705. Q Rev Biophys. 2001. PMID: 11838236 Review.
Cited by
-
Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities.Sci Rep. 2018 Jul 31;8(1):11477. doi: 10.1038/s41598-018-29850-4. Sci Rep. 2018. PMID: 30065306 Free PMC article.
-
IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.Int J Mol Sci. 2021 Oct 14;22(20):11067. doi: 10.3390/ijms222011067. Int J Mol Sci. 2021. PMID: 34681729 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous